Mary Woolley

by Mary Woolley, Research!America President and CEO. This entry was originally posted as a guest contribution to PhRMA’€™s Conversations forum. A shift in attitude among elected officials is necessary if this nation is to succeed in combating disease and stemming the rise of health care costs. Federal funding for the National Institutes of Health (NIH), the Food and Drug Administration (FDA), and other agencies that conduct medical and health research has not kept pace with scientific opportunity, jeopardizing our ability to find cures for deadly disease and to maintain our global competitive edge. Medical research has not risen to the upper ranks of our nation’€™s priorities in the halls...
by Mary Woolley, Research!America President and CEO. This entry was originally posted as a guest contribution to PhRMA’€™s Conversations forum. A shift in attitude among elected officials is necessary if this nation is to succeed in combating disease and stemming the rise of health care costs. Federal funding for the National Institutes of Health (NIH), the Food and Drug Administration (FDA), and other agencies that conduct medical and health research has not kept pace with scientific opportunity, jeopardizing our ability to find cures for deadly disease and to maintain our global competitive edge. Medical research has not risen to the upper ranks of our nation’€™s priorities in the halls...
July 9, 2013 The Senate subcommittee markup of the Labor-Health and Human Services-Education FY14 spending bill goes a step in the right direction in softening the blow sequestration has dealt to the hopes and expectations of patients and their families. Sequestration’€™s across-the-board spending cuts have sent no-confidence signals across the full ecosystem of medical research and innovation in the public and private sector. There’€™s a reason that, according to a recent national public opinion poll commissioned by Research!America, nearly half of Americans (48%) do not believe we are making enough progress in medical research in the U.S. This nation can’€™t push ahead forcefully with one...
Dear Research Advocate: Setting our nation’€™s sights high, rather than watching Rome burn; that’€™s the advice embedded in a recent op-ed authored by John R. Seffrin, PhD (CEO of the American Cancer Society and Research!America Board Member) and Michael Caligiuri, MD (CEO of the Ohio State University Comprehensive Cancer Center – James Cancer Center Hospital and Solove Research Institute). The authors advocate establishing a national plan, one that puts political differences aside and focuses on combating deadly and tremendously costly disease. There is a compelling argument to be made that if our nation wants to sustain a balanced budget, it must deploy a disease moonshot. If our nation...
Dear Research Advocate: Yesterday, I joined Diane Rehm and other guests on her nationally syndicated radio program to discuss how sequestration impacts “ordinary Americans.” I was struck by how deep and distressing the damage is, in so many sectors, including but not limited to our own. Yet somehow the pain is not acute enough to force action. What strikes me is how low our collective expectations have sunk when it comes to reinvigorating U.S. economic growth and prosperity. Our nation can do better; why don’€™t we maintain high expectations and hold our elected officials accountable for setting the policy stage to accomplish them? Policy makers should protect discretionary spending, make...
Dear Research Advocate: According to our new national public opinion poll on clinical trials and related topics, most Americans are willing to share their personal health data to advance research, and 72% would be willing to participate in a clinical trial if recommended by their doctor. This complements what we know from other polling, i.e. that Americans want research to proceed at a pace of scientific opportunity. Yet we continue to lose ground in the gridlocked political environment, which, by its inaction, is dashing the hopes of patients and families anxious for new therapies and cures. What’€™s wrong with this picture? It isn’€™t as though research hasn’€™t yielded both societal and...
Only Small Percentage say Health Care Professionals Have Ever Talked to Them about Medical Research ALEXANDRIA, Va. – June 12, 2013 – More than two-thirds (72%) of Americans say it’s likely they would participate in a clinical trial if recommended by their doctor, but only 22% say a doctor or other health care professional has ever talked to them about medical research, according to a new national public opinion poll commissioned by Research!America. A wide majority (80%) say they have heard of a clinical trial – more than half (53%) through the Internet and only 24% from a doctor or other health care provider. Only 16% of those polled say they or someone in their family have ever...
Dear Research Advocate: On Wednesday, the House Appropriations agriculture subcommittee approved the funding bill that includes the Food and Drug Administration. The bill allocates nearly $100 million above the post-sequester levels. Unfortunately, the baseline budgets in the House are so low that this increase is still lower than FY12 FDA funding. We must not fall into the trap of lowering our expectations and applauding an artificial victory. The true mark of success is funding that keeps up with need. We must keep working. As demonstrated particularly by the 18.6% cut targeted for the House LHHS appropriations FY14 budget, the pressure to shrink government by slashing discretionary...
Dear Research Advocate: Yesterday, President Obama tweeted about the effects of sequestration on medical research. From @barackobama, “The #sequester is slowing the pace of medical research, delaying the discovery of cures and treatments. Read more .” It is terrific that the president is helping drive increased attention to medical research. Our thanks to him and also to all who have joined our Memorial Day recess week of social media advocacy . The American Heart Association posted this great image to its Facebook page; we also thank Society for Neuroscience , BIO , The Endocrine Society , Melanoma Research Alliance , University of Maryland School of Medicine , CURE Epilepsy and UPenn...
Dear Research Advocate: I invite you to join me in speaking out during the Memorial Day congressional recess (May 27-31) as part of a social media campaign using the hashtag #curesnotcuts. Our goal is to continue to position research and innovation to improve health where it belongs: as a fundamental national priority that Americans can count on because their elected representatives rank it so highly. In our social media campaign, each day of the recess has a specific theme that can be customized with your information and patient/researcher stories. We have made it easy to get involved: click here to see sample social media messages, a list of selected congressional offices and their...

Pages

Sidebar Quote

You can change the image of things to come. But you can’t do it sitting on your hands … The science community should reach out to Congress and build bridges.
The Honorable John E. Porter